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Trends in the incidence 
and mortality of legionellosis 
in Japan: a nationwide 
observational study, 1999–2017
Shinnosuke Fukushima1, Hideharu Hagiya1*, Yuki Otsuka1, Toshihiro Koyama2 & 
Fumio Otsuka1 
This study examined temporal trend, seasonality, and geographical variations of legionellosis 
incidence and mortality in Japan. This nationwide observational study used the Japanese Vital 
Statistics and Infectious Diseases Weekly Report (1999–2017) data to calculate legionellosis crude 
and age-adjusted incidence and mortality rates per 100,000 population by age and sex. Incidence 
was compared among the 4 seasons and regional incidence among 47 prefectures. Of 13,613 (11,194 
men) people with legionellosis in Japan, 725 (569 men) were fatal. Increasing incidence trend occurred 
from 0.0004 (1999) to 1.37 (2017) per 100,000 population. People aged ≥ 70 years accounted for 43.1% 
overall; men’s age-adjusted incidence rate was consistently approximately five times higher than for 
women. Significantly higher incidence occurred in summer than in winter (p = 0.013). Geographically, 
highest incidence (≥ 2.0 per 100,000 population) occurred in Hokuriku District, with increasing trends 
in Hokkaido and middle-part of Japan. Estimated fatality rates decreased consistently at 5.9% (95% 
confidence interval: − 8.1, − 3.5) annually, from 1999 to 2017, with no trend change point. Increasing 
legionellosis incidence occurred in Japan during 1999–2017, with declining estimated fatality rates. In 
this aging society and warming world, disease clinical burden may further deteriorate in future due to 
increasing incidence trends.
Legionellosis, clinically classified into Legionella pneumonia (Legionnaires’ disease) and Pontiac fever, is caused 
by Legionella species, which grow in free-living, ubiquitous, freshwater and soil  amoebae1. The bacteria also con-
taminate artificial water systems, such as cooling towers, hot and cold water systems, and whirlpool spas, from 
where humans contract the disease via inhalation of contaminated  aerosols2. Legionella pneumonia has been 
known to cause severe respiratory disease requiring hospitalisation, potentially yielding higher fatality. Pontiac 
fever generally presents as a flu-like illness that resolves spontaneously.
Since the first clinical isolation of the organism from humans in the United States in  19773, growing numbers 
of legionellosis has been documented worldwide through surveillance systems to track the disease across North 
America, New Zealand, Australia, Europe, and other  countries4–9. In Ontario, for example, the overall incidence 
rate of legionellosis increased from 0.1 to 2.0 cases per 100,000 population between 2004 and  20136. By sex, cases 
were predominant in males (0.55 per 100,000) compared to females (0.35 per 100,000). Approximately three 
quarters of the cases were aged ≥ 50 years, with a strong linear trend between aging and incidence of the disease; 
incidence rate ratio per decade age increase is 1.67 rate per 100,000  population6.
In addition to the increasing trends, the seasonality of legionellosis incidence has been documented world-
wide. For example, a rise occurred in the number of notification of the disease from June–October in the 
United  States9, July–August in  Canada10, and August–November in  Europe4. In the southern hemisphere, in 
New Zealand for instance, its incidence increases between the late spring (September–November) and autumn 
(March–May)5.
Effects of climate and environmental changes on the onset of legionellosis are gradually being reported. 
According to a previous study in Italy, the increasing risk of legionellosis is associated with increases in pre-
cipitation and average  temperature11. Decreases in daily temperature excursion (difference between maximum 
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and minimum temperature over the course of 24 h during the incubation period of disease) and minimum 
temperature are also related with the  rise11. Climate change potentially leads to increased seawater temperature, 
drought, higher rainfall, rising sea levels, and flooding, which could play an important role in the transmission 
of waterborne diseases, including  legionellosis12, 13.
Case fatality of the disease also matters. In Europe, of 23,164 cases of the disease that were investigated 
between 2011 and 2015, 2,161 (9.3%) died, although the case fatality ratio decreased from 10.5% to 8.1%14. In 
Canada, 84% of legionellosis cases were hospitalised, with a fatality rate of 9.5% 6. In the United States, among 
5,503 cases of legionellosis with a known outcome, 456 (8.3%)  died15. These data suggest the severity of the 
disease that is commonly observed worldwide.
Based on public reports by the National Institute of Infectious Diseases (NIID) of Japan, the number of noti-
fications of legionellosis has also been increasing over time. However, to our knowledge, there are no published 
reports on the long-term trends in the incidence and mortality of legionellosis in Japan that consider seasonal 
and geographical variation. Our objectives for this study were to examine the temporal trend, seasonality, and 
geographical variations in the incidence of legionellosis in Japan over the past nearly 20 years. Also, we estimated 
the case-fatality rate of the disease in Japan, with its chronological trend. Analysing the recent trends in legionel-
losis incidence in Japan will inform the epidemiological characteristics at the global level and provide additional 
data for better public health control measures.
Results
The reported numbers, crude, and age-adjusted rates (AARs) of legionellosis incidence. Dur-
ing the study period, 13,613 individuals (11,194 men and 2419 women) developed legionellosis in Japan. The 
incidence of legionellosis rose from 1999 to 2017 (1733 cases overall; with 1433 in men and 300 in women) 
(Fig. 1). Distribution of the incidence by age and sex during 1999–2017 is depicted in Fig. 2a. The incidences 
increased with age in both sexes, and those aged ≥ 70 years accounted for 43.1% of the total number of cases. 
Crude rate and AAR of the incidence per 100,000 population increased, reaching up to 1.37 and 1.05 in 2017, 
respectively (Table 1). Between sexes, AAR of the incidence among men has remained approximately 5 times 
higher than that in women, between 1999 and 2017. Overall, the annual incidence rate increased at a rate of 
32.3% from 1999–2007, and then slowly but continuously rose by 11.1% from 2007–2017. The average annual 
percentage change (AAPC) of the incidence rate was 20.1% (95% confidence interval [95% CI]; 14.7 to 25.7) dur-
ing the entire study period. By sex, annual percentage change (APC) among men increased continuously with 
an AAPC of 19.8% (95% CI; 14.9 to 24.9). While among women, the APC increased by 8.3% between 2007 and 
























Urinary antigen test 
introduced by the Japanese Respiratory Society as a guideline since 2005
LAMP test
applied for medical insurance since 2011
Figure 1.  Chronological changes in the number of reported cases of legionellosis in Japan, 1999–2017. The 
urinary antigen test was introduced in a clinical guideline by the Japanese Respiratory Society in 2005. Then, 
LAMP (Loop-mediated Isothermal Amplification) method for the diagnosis of legionellosis was approved by 
the medical insurance in 2011.
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Seasonality of the incidence. Data between 2006 and 2017 (12 years) was applied for the seasonality 
comparison. Median numbers (interquartile ranges) of legionellosis incidence in winter, spring, summer, and 
autumn were 170 (135.25, 241); 197 (162, 289.5); 282.5 (241.75, 467.5); and 246.5 (190.75, 340), respectively. 
The Kruskal–Wallis test was used to calculate the P-value of < 0.001 among the 4 seasons, and Mann–Whitney U 
test with Bonferroni adjustment demonstrated a significant difference between winter and summer (p = 0.013) 
(Fig. 3).
Geographic distribution. We utilised the regional data (each of 47 prefectures in Japan) between 2013 and 
2017 (the last 5 years). 2 maps (Fig. 4a,b) showing differences of the crude- and age-adjusted incidence rates of 
legionellosis. Data in detail are as summarised in the table (Supplementary Table S1). The incidence rates were 
highest in 3 prefectures in the Hokuriku District, with ≥ 2.0 per 100,000 population. Toyama Prefecture had the 
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Figure 2.  Age-sex distribution of the incidence (a) and number of fatal cases (b) of legionellosis in Japan, 
1999–2017.
Table 1.  Numbers, crude rates (CR), and age-adjusted rates (AAR) of incidence and mortality of legionellosis 
per 100,000 population in Japan, 1999–2017.
Year
Incidence Mortality
Case no. (total) CR (total) AAR (total) AAR (men) AAR (women) Case no. (total) CR (total) AAR (total)
1999 56 0.04 0.04 0.07 0.02 11 0.01 0.01
2000 154 0.12 0.12 0.20 0.05 12 0.01 0.01
2001 86 0.07 0.06 0.12 0.01 13 0.01 0.01
2002 139 0.13 0.13 0.21 0.04 15 0.01 0.01
2003 146 0.11 0.11 0.19 0.03 14 0.01 0.01
2004 161 0.13 0.12 0.22 0.01 8 0.01 0.01
2005 211 0.22 0.20 0.36 0.04 21 0.02 0.01
2006 518 0.41 0.36 0.64 0.09 31 0.02 0.02
2007 668 0.52 0.45 0.73 0.19 31 0.02 0.02
2008 892 0.70 0.60 0.94 0.26 46 0.04 0.03
2009 717 0.56 0.47 0.78 0.18 58 0.05 0.03
2010 751 0.59 0.49 0.83 0.17 43 0.03 0.03
2011 818 0.64 0.53 0.88 0.18 56 0.04 0.03
2012 899 0.71 0.57 0.95 0.20 58 0.05 0.03
2013 1124 0.88 0.72 1.23 0.21 64 0.05 0.03
2014 1248 0.98 0.76 1.23 0.30 65 0.05 0.03
2015 1592 1.25 0.98 1.66 0.32 59 0.05 0.03
2016 1602 1.26 0.98 1.67 0.29 67 0.05 0.03
2017 1733 1.37 1.05 1.77 0.33 53 0.04 0.03
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Table 2.  Trend analysis in crude rates of the incidence and mortality of legionellosis per 100,000 population 
by sex, 1999–2017. APC annual percentage change, CI confidence interval.
Period 1 Period 2 Period 3
Entire study 
period




All 1999–2007 32.3 (19.0 to 47.0) 2007–2017 11.1 (7.8 to 14.5) 20.1 (14.7 to 25.7)
 Men 1999–2007 31.1 (19.1 to 44.4) 2007–2017 11.4 (8.3 to 14.6) 19.8 (14.9 to 24.9)
 Women 1999–2004 −7.3 (−38.8 to 40.5) 2004–2007 101.5 (−44.1 to 626.7) 2007–2017 8.3 (3.7 to 13.1) 15.0 (−7.4 to 43)
Mortality
All 1999–2017 −5.9 (−8.1 to −3.5) −5.9 (−8.1 to −3.5)
 Men 1999–2007 −13.1 (−21.6 to −3.6) 2007–2011 11.5 (−17.8 to 51.3) 2011–2017
−14.5 (−21.9 to 
−6.5)
−8.6 (−15.5 to 
−1.3)
 Women 1999–2017 −5.2 (−8.0 to −2.2) −5.2 (−8.0 to −2.2)

































Figure 3.  Comparison of the incidence of legionellosis among the 4 seasons, 2006–2017. Shown are the box 
and whisker plots with median and 10th to 90th percentiles. Mann–Whitney U test revealed a significant 
difference (p = 0.013) between winter and summer.
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(2.04). Otherwise, no notable regional biases were observed. Regional increasing trends were examined by the 
Joinpoint analysis, which showed a different regional distribution. During the current 5  years, 7 prefectures 
showed statistically increasing trends in the incidence rates of legionellosis (Fig. 4c). The highest APC was seen 
in Tokushima (64.5%), followed by Wakayama (27.7%) and Gifu (24.7%).
The reported numbers, crude, and AARs of death cases of legionellosis. During the study period, 
725 fatal cases (569 men and 156 women) were reported in Japan. All the death cases were legionella pneumonia 
(A48.1), not including Pontiac fever (A48.2). Population aged ≥ 70 years accounted for 67% of the fatal cases; the 
number of death cases rose with age, with a peak at 75–79 years in men and 85–89 years in women (Fig. 2b). The 
number of deaths increased from 1999 to 2017 (53 cases overall; 41 in men and 12 in women). Both crude rate 
and AAR per 100,000 population in the last decade ranged between 0.03 and 0.05. Compared to the younger 
generations (< 50 years and 50–69 years), more deaths were observed in those aged ≥ 70 years (Fig. 5). Both in 
men and women, the number of deaths were very infrequent among those aged < 50 years. Compared to men, 
almost all the death cases in women were reported in those aged ≥ 70 years (Supplementary Figure  S1).
The trend in the estimated fatality rate of legionellosis is shown in Fig. 6. The overall estimated fatality rates 
decreased continuously at a rate of 5.9% (95% CI; − 8.1, − 3.5) annually from 1999 to 2017, without a trend change 
point. The declining trend was far significant in men (− 8.6%) than in women (− 5.2%) (Table 2).
Figure 4.  Incidence rates of legionellosis (a) crude incidence rates; (b) age-adjusted incidence rates; (c) 
trend analysis, 2013–2017. In the trend analysis, we calculated the annual percentage change in each of the 47 
prefectures by joinpoint analysis.
Figure 5.  Trends in the number of fatal cases by age category for legionellosis in Japan, 1999–2017. The figure 
shows the trends in the number of fatal cases by age group and an increase in incidence especially in those aged 
over 70 years from 1999 to 2017.
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Discussion
We herein uncovered trends in the incidence and estimated fatality of legionellosis in Japan over nearly 2 decades 
by utilising a national database that is open to the public. Notably, we also analysed seasonality and regionality 
of the disease across the country; which has yet to be well described in the literature.
Similar to other  countries4–9, the number of legionellosis incidence has increased continuously in Japan with 
0.0004 to 1.37 reported cases per 100,000 population from 1999 to 2017 (Fig. 1). According to the  NIID16, there 
was a sharp increase in the number of notifications after 2005 when the Legionella urinary antigen test was 
introduced as recommended in the clinical guidelines of the Japanese Respiratory Society. Internationally, the 
use of the urinary antigen test has been recommended for all patients with community-acquired pneumonia 
who require  hospitalisation17. Thus, we speculate that the urinary antigen test was also promoted in Japanese 
clinical environments, for moderate or severe pneumonia cases, resulting in the increased numbers of appropri-
ate diagnosis. The reported number of the disease then showed a plateau level for a few years, which again has 
trailed a rising trend until the end of the study period. This change can be explained by an availability of the 
loop-mediated isothermal amplification (LAMP) test in 2011, newly listed as an officially-approved test that is 
covered by the medical insurance. Focusing on sex, men accounted for the majority of the cases in both incidence 
and mortality, which has also been mentioned in previous  literatures2, 18. This sex difference can be explained by 
the predisposing risk factors of the disease, including current/former smoking and heavy alcohol  drinking19. As 
the analysis was based on aggregated publicly available data, we were unable to investigate underlying conditions 
in individuals with legionellosis.
As previously commented in a related  article5, several factors can explain the increasing trend of legionellosis 
cases. The growing awareness among physicians has resulted in increases in the number of specimens submitted 
for the legionella-specific tests as described above. Actually, in Europe, it has been mentioned that improved 
surveillance was attributed to the continued increase of legionellosis  incidence20, 21. Although nearly 90% cases 
of legionellosis in Japan has been diagnosed using the urinary Legionella  antigen16, the detection rate based on 
the recently-available LAMP method is better than  that22. Thus, the clinical incorporation of LAMP testing, 
starting from 2011, is also a key factor in the growing number of legionellosis in Japan. Additionally, the rise 
in the number of vulnerable people with risk factors for the disease, such as overlaps of underlying diseases, 
immunosuppressive drugs, and aging, can be attributed to the increasing trend of the legionellosis  incidence23.
Of these causes, we consider age as an important factor. In this study, we discovered that legionellosis mainly 
involved the population aged ≥70 years; they represented approximately over 40% of all the reported cases 
(Fig. 2). A previous study also showed a higher number of cases in people aged >65 years, especially those with 
debilitating  conditions19. In this rapidly-greying population, the clinical impact of the disease will continue to 
rise. The observed increasing trends of legionellosis in Japan are alarming to other countries as well, where aging 
is progressing.
Our study also suggested a seasonality of legionellosis incidence, that is more common in summer than winter 
(Fig. 3). Previous studies revealed that legionellosis appears more frequently during summer-autumn seasons 
rather than at other times of the year in the Northern  Hemisphere4, 9, 10. This has possibly been accelerated by 
warmer and humid weather that we have been experiencing in recent  years5, 24. In literature, an increase was 
reported in temperature and rainfall, as well as higher relative humidity, which have been associated with a higher 
risk of  legionellosis20, 25. There is hardly a clear explanation, but the increased growth of Legionella bacteria in the 
warm environment is biologically  plausible26. The on-going global warming, including in  Japan27, may possibly 
explain the seasonality of legionellosis that may result in an increasing incidence of the disease in the future.
The regionality of legionellosis in Japan was also investigated in this study (Fig. 4). The incidence rates were 
highest in 3 prefectures in Hokuriku District (≥2.0 per 100,000 people). The trend analysis did not shown a recent 
increase in the incidence of legionellosis in these regions; however, there was a statistically significantly increase 
in the incidence of legionellosis in some other regions in Hokkaido and the middle-part of the country. There 
Figure 6.  Trends in the estimated case fatality rate of legionellosis in Japan, 1999–2017. The annual estimated 
case fatality rate is plotted to show an approximate curve. The trend analysis also shows a decrease in the 
estimated mortality from 1999–2017. For details, see Table 2.
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can be several confounding factors such as reporting bias, and we cannot provide a clear explanation for the 
regional differences. However, this is the first in the literature to uncover the regionality of the disease in Japan. 
The factors underlying these regional differences should be investigated in future research.
Our trend analysis suggested a decreasing trend in the estimated fatality of legionellosis in Japan, although 
the reported number of fatal cases has not been declining (Figs. 5 and 6). A case-series study also showed that 
the in-hospital case-fatality rate of legionellosis has decreased  recently19. The decreasing trend in legionellosis 
can be attributed to the development of widely-available testing methods. In the past, having less resources to 
diagnose the disease, patients with legionellosis might not have been treated appropriately in its early phase. 
A retrospective cohort study reported that delayed commencement of appropriate therapy is associated with 
increased  mortality28. Another study showed that difference in the sequence type of Legionella pneumophila 
was not associated with increased mortality, while delayed diagnosis by undetectable types led to delayed treat-
ment and worsened prognosis, suggesting the importance of early  diagnosis29. With the introduction of clinical 
laboratory diagnostic methods including bacterial culture, direct fluorescent antibody, and serologic testing, the 
case-fatality rate has decreased steadily since the mid-1980s to  199830. Currently, with the availability of the urine 
antigen test and LAMP test, an increasing number of legionellosis is being diagnosed in Japan, contributing to 
reduced fatality. In addition, establishment of effective treatment for legionellosis (azithromycin and fluoroqui-
nolone agents)31, 32 has also contributed to the declining fatal rates.
This study made a strong point of statistically analysing the recent trends in legionellosis incidence in Japan 
using the national database in about 2 decades. Through this study, we revealed an increasing trend in incidence, 
seasonality, regionality, and decreasing estimated fatality of legionellosis in Japan. Several limitations of the study 
should also be mentioned. First, under-reporting of the disease could have resulted in an underestimation of 
legionellosis. While misclassification of the disease could be minimal since the diagnosis of the disease is con-
sidered to be based on specific tests of urinary antigen and LAMP tests. The LAMP test used in Japan can detect 
11 Legionella species including L. pneumophila33; but it does not detect all Legionella species. According to the 
Legionella Reference Centre in Japan, of 427 Legionella species isolated between 2008 and 2016, only 8 (1.8%) 
species other than L. pneumophila cause  legionellosis34. Thus, we believe that the contribution of unidentified 
Legionella species to the incidence and mortality of legionellosis in Japan has decreased since the introduction 
of the LAMP test in 2011. Globally, the prevalent strains vary by  region35, so the contribution of unidentified 
Legionella species may be higher in some other countries. Second, the case fatality rate was calculated by using 
the overall number of deaths and the total notification reports of the legionellosis cases. Appropriately, the case 
fatality rate should have been derived from individual data, not aggregated data. Thus, we would rather refer to 
this as an estimated case fatality rate. Third, the reliability of the death certificate data, from which legionellosis 
as an underlying cause of mortality was extracted, is uncertain; this is mainly due to fewer number of associated 
studies. As might be expected, there could have been under-reporting of cases. However, sensitivity, as well as 
the positive predictive value of death certificate data for the disease is reportedly  adequate36, and thus, we believe 
that our trend analysis possibly reflects the entire picture of legionellosis in Japan. Fourth, due to the unavail-
ability of data, our study lacked age information on the incidence of legionellosis among those aged ≥ 70 years. 
Finally, due to the absence of clinical data, we could not determine whether legionellosis was directly associated 
with the outcome in the reported patients. Despite these limitations, this study provides prominent findings to 
deeply understand the prevalence and characteristics of legionellosis in Japan.
In summary, we conducted a trend analysis of legionellosis in Japan from 1999 to 2017. The incident cases 
increased continuously during the study period; however, the estimated case fatality rates favourably declined. 
With increasing awareness among the physicians, further improvement in the diagnostic test, the growing num-
ber of ageing people, and the warming temperature, the incidence of legionellosis will be on an increasing trend. 
Our study informs the current trend and characteristics of the disease in Japan, providing prominent findings 
for better policy-making to further decrease the incidence and fatality.
Methods
Data source. This was a 19-year retrospective observational study including data from 1999 to 2017. The 
authors assert that all procedures contributing to this work comply with the ethical standards of the relevant 
national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, 
as revised in 2008. Ethics approval was obtained from the institutional review board of the Okayama University 
Hospital (No. 1910–009).
The requirement for informed consent was waived because the study was a retrospective analysis of routinely 
collected data. The requirement for informed consent was waived by the ethics committee/IRB of Okayama Uni-
versity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital 
because the study was a retrospective analysis of routinely collected data.
Data for the new cases of legionellosis were obtained from the Infectious Diseases Weekly Report,  Japan37. 
Since 1999 April, clinical data on patients with stipulated diseases have been accumulated at the NIID, based 
on the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the 
Infectious Diseases Control Law). Legionellosis is one of the notifiable diseases, classified under Category IV 
Infectious Diseases that should be immediately reported after  diagnosis38. Thus, when patients with the disease 
are diagnosed, medical practitioners are responsible for informing the public health centres, the reported data 
are then summarised by the National Epidemiologic Surveillance of Infectious Disease and made available to 
the public, in an online  website37. Accordingly, cases diagnosed as legionellosis are well reported throughout 
the entire country. In this study, the incidence data of legionellosis included both for Legionella pneumonia and 
Pontiac fever. To compare the seasonality of the onset of legionellosis in Japan, we divided a whole year into four 
seasons: winter (1st to 13th week); spring (14th to 26th week); summer (27th to 39th week); and autumn (40th 
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to 52nd; or 53rd week). To avoid reporting bias when calculating seasonality, we excluded the year when the 
total number of the annual incidence was < 500 cases. To compare the regional incidence and increasing trend 
of legionellosis in Japan, we calculated the mean rate per 100,000 population and the APC for each region. We 
utilised a geography software (https:// www. sinfo nica. or. jp/ kanko/ estre la/ refer/ s35/ index. html) to draw differ-
ences in notification rates and its increasing trends among  prefectures39.
Data on the number of deaths due to legionellosis were collected from the vital statistics, provided by the 
Japanese Ministry of Health, Labour, and  Welfare40. Definitions of legionellosis deaths were according to the 
International Statistical Classification of Diseases and Related Health Problems coding system (tenth edi-
tion) as previously reported; legionella pneumonia (A48.1) and Pontiac fever (A48.2)18, 41. We categorised age 
as < 50 years, 50–69 years, and ≥ 70 years. To improve comparability, we adopted the direct standardisation 
method and calculated the AARs of incidence and mortality, based on the Japanese population in 1999, the first 
year of the study period. For the incidence of those aged 0 to 70 years, we applied 5-yearly age groups for the 
standardisation. For those aged ≥ 70 years, the 5-yearly age group data was unavailable; thus, we treated the data 
for those aged ≥ 70 years as a combined number. We calculated the estimated fatality rate by dividing the number 
of fatal cases by the number of the reported incident cases in each year.
Statistical analyses and data processing. We calculated the incidence and mortality crude and AARs 
of legionellosis. We used the 1999 population as the standard population for calculating the age-adjusted inci-
dence rates. To estimate the trends in the AAR, the Joinpoint regression model was applied by sex and age using 
the Joinpoint Regression Program, version 4.5.0.1, June 2017 (Statistical Research and Applications Branch, 
National Cancer Institute)42. The analysis identified the year when the significant trend changes occurred and 
estimated the magnitude of the increase or decrease. Each joinpoint showed a statistically significant change in 
trend, and APC was calculated for each of those trends by means of the generalised linear models assuming a 
Poisson  distribution43. Also, the AAPC in the entire period was estimated. For the comparison of the incidence 
among the 4 seasons, we applied the Kruskal–Wallis analysis using the EZR software, a graphic user interface 
for the R 3.5.2 software (The R Foundation for Statistical Computing, Vienna, Austria)44. All the processes of 
data collections and calculations were performed independently and in duplicate by 2 distinct researchers (SF 
and YO) to ensure accuracy of the analysis. All reported P values < 0.05 were considered statistically significant.
Data availability
The datasets generated and analysed during the current study are available from the corresponding author on 
reasonable request.
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